Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European Cohort-Reference-Cited by-同舟云学术

Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European Cohort

Published:2021-10 Issue:4 Volume:80 Page:400-404
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Würnschimmel Christoph,Pose Randi Marisa,Wenzel Mike,Tian Zhe,Incesu Reha-Baris,Karakiewicz Pierre,Graefen Markus,Tilki Derya

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality: results from the International Staging Collaboration for Cancer of the Prostate;Dess;JAMA Oncol,2020

2. Prostate cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual;Buyyounouski;CA Cancer J Clin,2017

3. National Cancer Institute. Surveillance, Epidemiology and End Results (SEER) program. www.seer.cancer.gov. Access date 15th June 2021.

4. National Comprehensive Cancer Network. Clinical practice guidelines on prostate cancer version 2.2020. www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Access date 15th June 2021.

5. The University of California, San Francisco Cancer of the Prostate Risk Assessment Score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy;Cooperberg;J Urol,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Pre-Operative Total Prostate-Specific Antigen and Survivorship of Prostate Cancer following Radical Prostatectomy: A Systematic Review;Medical Principles and Practice;2023-12-22

2. Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy;Radiology;2023-11-01

3. Prognostic differences among Grade Group 4 subgroups in robotic‐assisted radical prostatectomy;BJUI Compass;2022-06-02

4. Re: Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-specific Mortality Results from the International Staging Collaboration for Cancer of the Prostate;European Urology;2022-03

5. Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups;European Urology;2022-02